Followers
0
Following
1
Blog Posts
0
Threads
172
Blogs
Threads
Portfolio
Follower
Following
2020-12-30 10:15 | Report Abuse
collect more before March 2020
2020-12-30 10:13 | Report Abuse
last two day missing the boat...but today i sense renew interest or recovery of price from yesterday
2020-12-30 09:39 | Report Abuse
collection some more.. below 0.50
2020-12-29 10:18 | Report Abuse
technically still strong buy..
2020-12-29 09:39 | Report Abuse
time to grab cheap below 0.6
2020-12-24 19:03 | Report Abuse
Clinical trial phase 3 for any vaccine should be the critical phase to asses the adverse side effect the may arise..therefore..the move to use en mass before the phase 3 clinical trial end.will create much problem.
2020-12-06 13:09 | Report Abuse
very vaccine jab need a pair of new glove... the glove still in play with lower note..
2020-12-04 15:14 | Report Abuse
murah2 get additional stocks to hold
2020-11-30 09:44 | Report Abuse
Phase III already started
The Chinese company CanSino Biologics developed a vaccine based on an adenovirus called Ad5, in partnership with the Institute of Biology at the country’s Academy of Military Medical Sciences. In May, they published promising results from a Phase 1 safety trial, and in July they reported that their Phase 2 trials demonstrated the vaccine produced a strong immune response. In an unprecedented move, the Chinese military approved the vaccine on June 25 for a year as a “specially needed drug.” CanSino would not say whether vaccination would be mandatory or optional for soldiers. Starting in August, CanSino began running Phase 3 trials in a number of countries, including Saudi Arabia, Pakistan and Russia.
Updated Sept. 24( New York Times)
2020-11-25 22:54 | Report Abuse
Solution the forunner in vaccine race..
Stock: [SOLUTN]: SOLUTION GROUP BERHAD
2020-12-30 10:16 | Report Abuse
colecting piece by piece since September..before rm 1 mark